NLS Pharma AG announced this week successful results of its ADHD clinical trial using Mazindol, a non-stimulant. The adult-focused study found that while the drug is not a traditional stimulant treatment of adult attention deficit hyperactive disorder (ADHD),...
According to an article via South Bend Tribune, “Eli Lilly & Co. reported Wednesday that an experimental medication might slow mild Alzheimer’s if people take it early enough, one of a handful of drugs in late-stage testing in the frustrating hunt for a...
According to FDANews.com, “Global drug regulators have reduced drug approval times over the last 10 years, and while the FDA remains the fastest at approving new drugs, other regulators are closing the gap.” For more information, visit: ...
